Published: 12 Oct 2021

In the current pandemic era, this is the right momentum for healthtech (health technology) developers in Indonesia. Ease of access and services that suit the needs of the community have made many people begin to entrust their health to healthtech (dailysocial.id)

The use of telemedicine services (health consultations with remote doctors) offered by a number of domestic healthtech startups has increased in the last two years. However, this increase does not necessarily make online health platform managers and their partner doctors earn large incomes. Why?

There are several factors. First, according to a number of partner doctors interviewed by id.techinasia.com, the average telemedicine platform manager charges a fairly high commission fee, which is 20% of the rate set by each partner doctor for each consultation session.

Second, the income that doctors get from this service is also not much. It is still much lower than the similar income obtained from doing face-to-face practice.

Third, the amount of commission rates withdrawn from the platform manager will undoubtedly continue to increase. This is in line with the increasingly massive use of telemedicine services in the future.

Fourth, a number of healthtech companies are also innovating to offer other products to increase their sources of income. Starting from purchasing drugs through mobile applications, to providing health insurance on their respective platforms.

Even so, investors are still interested to see how high the acceptance of the healthcare platform market has been since the pandemic lasted so far. Therefore, funding in the healthtech sector will also increase during 2021. According to a report from a venture capital company named Venturra, as quoted by id.techinasia.com, the amount of investment flowing into this industry in Southeast Asia has reached US$639 million or equivalent to IDR 9 trillion. This has almost tripled compared to the previous year. (Ruhmaya Nida Wathoni. Infographics: crunchbase.com)